PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 223 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.

Quarter-by-quarter ownership
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,709
+542.5%
56,746
+542.3%
0.00%
+300.0%
Q2 2023$266
-16.9%
8,8350.0%0.00%
-50.0%
Q1 2023$320
+1.6%
8,8350.0%0.00%0.0%
Q4 2022$315
-99.9%
8,8350.0%0.00%0.0%
Q3 2022$299,000
+16.8%
8,8350.0%0.00%
+100.0%
Q2 2022$256,000
-10.5%
8,8350.0%0.00%0.0%
Q1 2022$286,000
+10.9%
8,8350.0%0.00%0.0%
Q4 2021$258,000
+9.3%
8,8350.0%0.00%0.0%
Q3 2021$236,000
-13.2%
8,8350.0%0.00%0.0%
Q2 2021$272,000
+17.7%
8,8350.0%0.00%0.0%
Q1 2021$231,000
+4.1%
8,8350.0%0.00%0.0%
Q4 2020$222,000
+20.7%
8,8350.0%0.00%0.0%
Q3 2020$184,000
-12.4%
8,8350.0%0.00%0.0%
Q2 2020$210,000
+32.1%
8,8350.0%0.00%0.0%
Q1 2020$159,000
-13.1%
8,835
+14.3%
0.00%0.0%
Q4 2019$183,000
-13.7%
7,7320.0%0.00%0.0%
Q3 2019$212,000
-17.2%
7,7320.0%0.00%
-50.0%
Q2 2019$256,000
-5.5%
7,7320.0%0.00%0.0%
Q1 2019$271,000
+5.4%
7,7320.0%0.00%0.0%
Q4 2018$257,000
-33.9%
7,7320.0%0.00%0.0%
Q3 2018$389,000
+37.9%
7,732
+64.1%
0.00%0.0%
Q2 2018$282,000
+30.6%
4,7130.0%0.00%
+100.0%
Q1 2018$216,000
+14.9%
4,7130.0%0.00%0.0%
Q4 2017$188,0004,7130.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders